Report Thumbnail
Product Code LP0911615527TJ
Published Date 2026/6/2
English88 PagesGlobal

Global Dextromethorphan Hydrobromide Syrups Market Growth 2026-2032 ‐ Pharmaceutical / LifeSciense Market


Report Thumbnail
Product Code LP0911615527TJ
Published Date 2026/6/2
English 88 PagesGlobal

Global Dextromethorphan Hydrobromide Syrups Market Growth 2026-2032 ‐ Pharmaceutical / LifeSciense Market



Abstract

This report provides a comprehensive analysis of the global Dextromethorphan Hydrobromide Syrups market, which is projected to grow steadily through 2032. As a vital over-the-counter cough suppressant for treating dry cough symptoms, the market is segmented by type, application, and key geographic regions including the Americas, APAC, and Europe. The study evaluates competitive landscapes, major industry players, and market drivers to identify emerging growth opportunities and strategic trends across various healthcare sectors.

Related Questions

US$ 17.03 million in 2025; US$ 22.87 million in 2032

4.4% (2026 to 2032)

Tangshan Fule Pharmaceutical Co., Ltd., Jiangsu Guangcheng Pharmaceutical Co., Ltd., Hainan Sanye Pharmaceutical Factory Co., Ltd., Harbin Taihua Pharmaceutical Co., Ltd., Bayer Healthcare Co., Ltd., Shanghai Meiyu Pharmaceutical Co., Ltd., Hubei Phoenix Baiyunshan Pharmaceutical Co., Ltd., Yili Pharmaceutical (Luoding) Co., Ltd., Jiangxi Yaodu Renhe Pharmaceutical Co., Ltd.


Summary

Market Overview

Global Market Projection

The global Dextromethorphan Hydrobromide Syrups market is predicted to grow from US$ 17.03 million in 2025 to US$ 22.87 million in 2032, representing an expected compound annual growth rate (CAGR) of 4.4% from 2026 to 2032.

Product Description

Dextromethorphan hydrobromide syrup is a commonly used over-the-counter cough suppressant. Its primary ingredient, dextromethorphan hydrobromide, is utilized to relieve dry cough symptoms associated with conditions such as colds, acute bronchitis, or chronic bronchitis. The syrup functions by acting on the cough center within the central nervous system to inhibit unnecessary cough reflexes without negatively affecting respiratory function.

Regional Market Outlook

  • United States: The market for Dextromethorphan Hydrobromide Syrups in the United States is estimated to experience growth from 2025 through 2032.
  • China: The market for Dextromethorphan Hydrobromide Syrups in China is estimated to undergo expansion from 2025 through 2032.
  • Europe: The market for Dextromethorphan Hydrobromide Syrups in Europe is estimated to see an increase from 2025 through 2032.

Market Segmentation

By Type

  • Compound Preparations
  • Conventional Preparations

By Application

  • Hospital
  • Clinic
  • Other

By Region

  • Americas
  • United States
  • Canada
  • Mexico
  • Brazil
  • APAC
  • China
  • Japan
  • Korea
  • Southeast Asia
  • India
  • Australia
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Russia
  • Middle East & Africa
  • Egypt
  • South Africa
  • Israel
  • Turkey
  • GCC Countries

Competitive Landscape

Key Industry Players

The following companies have been profiled based on primary expert input and analysis of company coverage, product portfolios, and market penetration:

  • Tangshan Fule Pharmaceutical Co., Ltd.
  • Jiangsu Guangcheng Pharmaceutical Co., Ltd.
  • Hainan Sanye Pharmaceutical Factory Co., Ltd.
  • Harbin Taihua Pharmaceutical Co., Ltd.
  • Bayer Healthcare Co., Ltd.
  • Shanghai Meiyu Pharmaceutical Co., Ltd.
  • Hubei Phoenix Baiyunshan Pharmaceutical Co., Ltd.
  • Yili Pharmaceutical (Luoding) Co., Ltd.
  • Jiangxi Yaodu Renhe Pharmaceutical Co., Ltd.

Market Concentration

In 2025, the two largest global companies in the Dextromethorphan Hydrobromide Syrups sector held a significant portion of the total market revenue.

About the Report

Research Scope

LP Information, Inc. (LPI) 's newest research report, the “Dextromethorphan Hydrobromide Syrups Industry Forecast,” reviews total global sales for 2025 and provides a comprehensive analysis of projected sales for the period of 2026 through 2032. The report offers detailed analysis in US$ millions, breaking down the industry by region, market sector, and sub-sector.

Analytical Focus

This Insight Report provides a comprehensive analysis of the global Dextromethorphan Hydrobromide Syrups landscape, highlighting key trends related to:

  • Product segmentation
  • Company formation
  • Revenue and market share
  • Latest developments
  • M&A activity

Furthermore, the report analyzes the strategies of leading global companies, focusing on their Dextromethorphan Hydrobromide Syrups portfolios and capabilities, market entry strategies, market positions, and geographic footprints. This provides insight into their unique positions within an accelerating global market.

Methodology and Insights

The report evaluates key market trends, drivers, and affecting factors shaping the global outlook. It breaks down forecasts by type, application, geography, and market size to identify emerging pockets of opportunity. Utilizing a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, the study offers a nuanced view of the current state and future trajectory of the industry. It presents a comprehensive overview of market shares and growth opportunities by product type, application, key manufacturers, and key regions/countries.

Key Questions Addressed

  • What is the 10-year outlook for the global Dextromethorphan Hydrobromide Syrups market?
  • What factors are driving Dextromethorphan Hydrobromide Syrups market growth, globally and by region?
  • Which technologies are poised for the fastest growth by market and region?
  • How do Dextromethorphan Hydrobromide Syrups market opportunities vary by end market size?
  • How does Dextromethorphan Hydrobromide Syrups break out by Type and by Application?

Table of Contents

  • 1 Scope of the Report

    • 1.1 Market Introduction
    • 1.2 Years Considered
    • 1.3 Research Objectives
    • 1.4 Market Research Methodology
    • 1.5 Research Process and Data Source
    • 1.6 Economic Indicators
    • 1.7 Currency Considered
    • 1.8 Market Estimation Caveats
  • 2 Executive Summary

    • 2.1 World Market Overview
      • 2.1.1 Global Dextromethorphan Hydrobromide Syrups Annual Sales 2021-2032
      • 2.1.2 World Current & Future Analysis for Dextromethorphan Hydrobromide Syrups by Geographic Region, 2021, 2025 & 2032
      • 2.1.3 World Current & Future Analysis for Dextromethorphan Hydrobromide Syrups by Country/Region, 2021, 2025 & 2032
    • 2.2 Dextromethorphan Hydrobromide Syrups Segment by Type
      • 2.2.1 Compound Preparations
      • 2.2.2 Conventional Preparations
      • 2.2.3 Dextromethorphan Hydrobromide Syrups Sales by Type
        • 2.2.3.1 Global Dextromethorphan Hydrobromide Syrups Sales Market Share by Type (2021-2026)
        • 2.2.3.2 Global Dextromethorphan Hydrobromide Syrups Revenue and Market Share by Type (2021-2026)
        • 2.2.3.3 Global Dextromethorphan Hydrobromide Syrups Sale Price by Type (2021-2026)
    • 2.3 Dextromethorphan Hydrobromide Syrups Segment by Application
      • 2.3.1 Hospital
      • 2.3.2 Clinic
      • 2.3.3 Other
      • 2.3.4 Dextromethorphan Hydrobromide Syrups Sales by Application
        • 2.3.4.1 Global Dextromethorphan Hydrobromide Syrups Sale Market Share by Application (2021-2026)
        • 2.3.4.2 Global Dextromethorphan Hydrobromide Syrups Revenue and Market Share by Application (2021-2026)
        • 2.3.4.3 Global Dextromethorphan Hydrobromide Syrups Sale Price by Application (2021-2026)
  • 3 Global by Company

    • 3.1 Global Dextromethorphan Hydrobromide Syrups Breakdown Data by Company
      • 3.1.1 Global Dextromethorphan Hydrobromide Syrups Annual Sales by Company (2021-2026)
      • 3.1.2 Global Dextromethorphan Hydrobromide Syrups Sales Market Share by Company (2021-2026)
    • 3.2 Global Dextromethorphan Hydrobromide Syrups Annual Revenue by Company (2021-2026)
      • 3.2.1 Global Dextromethorphan Hydrobromide Syrups Revenue by Company (2021-2026)
      • 3.2.2 Global Dextromethorphan Hydrobromide Syrups Revenue Market Share by Company (2021-2026)
    • 3.3 Global Dextromethorphan Hydrobromide Syrups Sale Price by Company
    • 3.4 Key Manufacturers Dextromethorphan Hydrobromide Syrups Producing Area Distribution, Sales Area, Product Type
      • 3.4.1 Key Manufacturers Dextromethorphan Hydrobromide Syrups Product Location Distribution
      • 3.4.2 Players Dextromethorphan Hydrobromide Syrups Products Offered
    • 3.5 Market Concentration Rate Analysis
      • 3.5.1 Competition Landscape Analysis
      • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
    • 3.6 New Products and Potential Entrants
    • 3.7 Market M&A Activity & Strategy
  • 4 World Historic Review for Dextromethorphan Hydrobromide Syrups by Geographic Region

    • 4.1 World Historic Dextromethorphan Hydrobromide Syrups Market Size by Geographic Region (2021-2026)
      • 4.1.1 Global Dextromethorphan Hydrobromide Syrups Annual Sales by Geographic Region (2021-2026)
      • 4.1.2 Global Dextromethorphan Hydrobromide Syrups Annual Revenue by Geographic Region (2021-2026)
    • 4.2 World Historic Dextromethorphan Hydrobromide Syrups Market Size by Country/Region (2021-2026)
      • 4.2.1 Global Dextromethorphan Hydrobromide Syrups Annual Sales by Country/Region (2021-2026)
      • 4.2.2 Global Dextromethorphan Hydrobromide Syrups Annual Revenue by Country/Region (2021-2026)
    • 4.3 Americas Dextromethorphan Hydrobromide Syrups Sales Growth
    • 4.4 APAC Dextromethorphan Hydrobromide Syrups Sales Growth
    • 4.5 Europe Dextromethorphan Hydrobromide Syrups Sales Growth
    • 4.6 Middle East & Africa Dextromethorphan Hydrobromide Syrups Sales Growth
  • 5 Americas

    • 5.1 Americas Dextromethorphan Hydrobromide Syrups Sales by Country
      • 5.1.1 Americas Dextromethorphan Hydrobromide Syrups Sales by Country (2021-2026)
      • 5.1.2 Americas Dextromethorphan Hydrobromide Syrups Revenue by Country (2021-2026)
    • 5.2 Americas Dextromethorphan Hydrobromide Syrups Sales by Type (2021-2026)
    • 5.3 Americas Dextromethorphan Hydrobromide Syrups Sales by Application (2021-2026)
    • 5.4 United States
    • 5.5 Canada
    • 5.6 Mexico
    • 5.7 Brazil
  • 6 APAC

    • 6.1 APAC Dextromethorphan Hydrobromide Syrups Sales by Region
      • 6.1.1 APAC Dextromethorphan Hydrobromide Syrups Sales by Region (2021-2026)
      • 6.1.2 APAC Dextromethorphan Hydrobromide Syrups Revenue by Region (2021-2026)
    • 6.2 APAC Dextromethorphan Hydrobromide Syrups Sales by Type (2021-2026)
    • 6.3 APAC Dextromethorphan Hydrobromide Syrups Sales by Application (2021-2026)
    • 6.4 China
    • 6.5 Japan
    • 6.6 South Korea
    • 6.7 Southeast Asia
    • 6.8 India
    • 6.9 Australia
    • 6.10 China Taiwan
  • 7 Europe

    • 7.1 Europe Dextromethorphan Hydrobromide Syrups by Country
      • 7.1.1 Europe Dextromethorphan Hydrobromide Syrups Sales by Country (2021-2026)
      • 7.1.2 Europe Dextromethorphan Hydrobromide Syrups Revenue by Country (2021-2026)
    • 7.2 Europe Dextromethorphan Hydrobromide Syrups Sales by Type (2021-2026)
    • 7.3 Europe Dextromethorphan Hydrobromide Syrups Sales by Application (2021-2026)
    • 7.4 Germany
    • 7.5 France
    • 7.6 UK
    • 7.7 Italy
    • 7.8 Russia
  • 8 Middle East & Africa

    • 8.1 Middle East & Africa Dextromethorphan Hydrobromide Syrups by Country
      • 8.1.1 Middle East & Africa Dextromethorphan Hydrobromide Syrups Sales by Country (2021-2026)
      • 8.1.2 Middle East & Africa Dextromethorphan Hydrobromide Syrups Revenue by Country (2021-2026)
    • 8.2 Middle East & Africa Dextromethorphan Hydrobromide Syrups Sales by Type (2021-2026)
    • 8.3 Middle East & Africa Dextromethorphan Hydrobromide Syrups Sales by Application (2021-2026)
    • 8.4 Egypt
    • 8.5 South Africa
    • 8.6 Israel
    • 8.7 Turkey
    • 8.8 GCC Countries
  • 9 Market Drivers, Challenges and Trends

    • 9.1 Market Drivers & Growth Opportunities
    • 9.2 Market Challenges & Risks
    • 9.3 Industry Trends
  • 10 Manufacturing Cost Structure Analysis

    • 10.1 Raw Material and Suppliers
    • 10.2 Manufacturing Cost Structure Analysis of Dextromethorphan Hydrobromide Syrups
    • 10.3 Manufacturing Process Analysis of Dextromethorphan Hydrobromide Syrups
    • 10.4 Industry Chain Structure of Dextromethorphan Hydrobromide Syrups
  • 11 Marketing, Distributors and Customer

    • 11.1 Sales Channel
      • 11.1.1 Direct Channels
      • 11.1.2 Indirect Channels
    • 11.2 Dextromethorphan Hydrobromide Syrups Distributors
    • 11.3 Dextromethorphan Hydrobromide Syrups Customer
  • 12 World Forecast Review for Dextromethorphan Hydrobromide Syrups by Geographic Region

    • 12.1 Global Dextromethorphan Hydrobromide Syrups Market Size Forecast by Region
      • 12.1.1 Global Dextromethorphan Hydrobromide Syrups Forecast by Region (2027-2032)
      • 12.1.2 Global Dextromethorphan Hydrobromide Syrups Annual Revenue Forecast by Region (2027-2032)
    • 12.2 Americas Forecast by Country (2027-2032)
    • 12.3 APAC Forecast by Region (2027-2032)
    • 12.4 Europe Forecast by Country (2027-2032)
    • 12.5 Middle East & Africa Forecast by Country (2027-2032)
    • 12.6 Global Dextromethorphan Hydrobromide Syrups Forecast by Type (2027-2032)
    • 12.7 Global Dextromethorphan Hydrobromide Syrups Forecast by Application (2027-2032)
  • 13 Key Players Analysis

    • 13.1 Tangshan Fule Pharmaceutical Co., Ltd.
      • 13.1.1 Tangshan Fule Pharmaceutical Co., Ltd. Company Information
      • 13.1.2 Tangshan Fule Pharmaceutical Co., Ltd. Dextromethorphan Hydrobromide Syrups Product Portfolios and Specifications
      • 13.1.3 Tangshan Fule Pharmaceutical Co., Ltd. Dextromethorphan Hydrobromide Syrups Sales, Revenue, Price and Gross Margin (2021-2026)
      • 13.1.4 Tangshan Fule Pharmaceutical Co., Ltd. Main Business Overview
      • 13.1.5 Tangshan Fule Pharmaceutical Co., Ltd. Latest Developments
    • 13.2 Jiangsu Guangcheng Pharmaceutical Co., Ltd.
      • 13.2.1 Jiangsu Guangcheng Pharmaceutical Co., Ltd. Company Information
      • 13.2.2 Jiangsu Guangcheng Pharmaceutical Co., Ltd. Dextromethorphan Hydrobromide Syrups Product Portfolios and Specifications
      • 13.2.3 Jiangsu Guangcheng Pharmaceutical Co., Ltd. Dextromethorphan Hydrobromide Syrups Sales, Revenue, Price and Gross Margin (2021-2026)
      • 13.2.4 Jiangsu Guangcheng Pharmaceutical Co., Ltd. Main Business Overview
      • 13.2.5 Jiangsu Guangcheng Pharmaceutical Co., Ltd. Latest Developments
    • 13.3 Hainan Sanye Pharmaceutical Factory Co., Ltd.
      • 13.3.1 Hainan Sanye Pharmaceutical Factory Co., Ltd. Company Information
      • 13.3.2 Hainan Sanye Pharmaceutical Factory Co., Ltd. Dextromethorphan Hydrobromide Syrups Product Portfolios and Specifications
      • 13.3.3 Hainan Sanye Pharmaceutical Factory Co., Ltd. Dextromethorphan Hydrobromide Syrups Sales, Revenue, Price and Gross Margin (2021-2026)
      • 13.3.4 Hainan Sanye Pharmaceutical Factory Co., Ltd. Main Business Overview
      • 13.3.5 Hainan Sanye Pharmaceutical Factory Co., Ltd. Latest Developments
    • 13.4 Harbin Taihua Pharmaceutical Co., Ltd.
      • 13.4.1 Harbin Taihua Pharmaceutical Co., Ltd. Company Information
      • 13.4.2 Harbin Taihua Pharmaceutical Co., Ltd. Dextromethorphan Hydrobromide Syrups Product Portfolios and Specifications
      • 13.4.3 Harbin Taihua Pharmaceutical Co., Ltd. Dextromethorphan Hydrobromide Syrups Sales, Revenue, Price and Gross Margin (2021-2026)
      • 13.4.4 Harbin Taihua Pharmaceutical Co., Ltd. Main Business Overview
      • 13.4.5 Harbin Taihua Pharmaceutical Co., Ltd. Latest Developments
    • 13.5 Bayer Healthcare Co., Ltd.
      • 13.5.1 Bayer Healthcare Co., Ltd. Company Information
      • 13.5.2 Bayer Healthcare Co., Ltd. Dextromethorphan Hydrobromide Syrups Product Portfolios and Specifications
      • 13.5.3 Bayer Healthcare Co., Ltd. Dextromethorphan Hydrobromide Syrups Sales, Revenue, Price and Gross Margin (2021-2026)
      • 13.5.4 Bayer Healthcare Co., Ltd. Main Business Overview
      • 13.5.5 Bayer Healthcare Co., Ltd. Latest Developments
    • 13.6 Shanghai Meiyu Pharmaceutical Co., Ltd.
      • 13.6.1 Shanghai Meiyu Pharmaceutical Co., Ltd. Company Information
      • 13.6.2 Shanghai Meiyu Pharmaceutical Co., Ltd. Dextromethorphan Hydrobromide Syrups Product Portfolios and Specifications
      • 13.6.3 Shanghai Meiyu Pharmaceutical Co., Ltd. Dextromethorphan Hydrobromide Syrups Sales, Revenue, Price and Gross Margin (2021-2026)
      • 13.6.4 Shanghai Meiyu Pharmaceutical Co., Ltd. Main Business Overview
      • 13.6.5 Shanghai Meiyu Pharmaceutical Co., Ltd. Latest Developments
    • 13.7 Hubei Phoenix Baiyunshan Pharmaceutical Co., Ltd.
      • 13.7.1 Hubei Phoenix Baiyunshan Pharmaceutical Co., Ltd. Company Information
      • 13.7.2 Hubei Phoenix Baiyunshan Pharmaceutical Co., Ltd. Dextromethorphan Hydrobromide Syrups Product Portfolios and Specifications
      • 13.7.3 Hubei Phoenix Baiyunshan Pharmaceutical Co., Ltd. Dextromethorphan Hydrobromide Syrups Sales, Revenue, Price and Gross Margin (2021-2026)
      • 13.7.4 Hubei Phoenix Baiyunshan Pharmaceutical Co., Ltd. Main Business Overview
      • 13.7.5 Hubei Phoenix Baiyunshan Pharmaceutical Co., Ltd. Latest Developments
    • 13.8 Yili Pharmaceutical (Luoding) Co., Ltd.
      • 13.8.1 Yili Pharmaceutical (Luoding) Co., Ltd. Company Information
      • 13.8.2 Yili Pharmaceutical (Luoding) Co., Ltd. Dextromethorphan Hydrobromide Syrups Product Portfolios and Specifications
      • 13.8.3 Yili Pharmaceutical (Luoding) Co., Ltd. Dextromethorphan Hydrobromide Syrups Sales, Revenue, Price and Gross Margin (2021-2026)
      • 13.8.4 Yili Pharmaceutical (Luoding) Co., Ltd. Main Business Overview
      • 13.8.5 Yili Pharmaceutical (Luoding) Co., Ltd. Latest Developments
    • 13.9 Jiangxi Yaodu Renhe Pharmaceutical Co., Ltd.
      • 13.9.1 Jiangxi Yaodu Renhe Pharmaceutical Co., Ltd. Company Information
      • 13.9.2 Jiangxi Yaodu Renhe Pharmaceutical Co., Ltd. Dextromethorphan Hydrobromide Syrups Product Portfolios and Specifications
      • 13.9.3 Jiangxi Yaodu Renhe Pharmaceutical Co., Ltd. Dextromethorphan Hydrobromide Syrups Sales, Revenue, Price and Gross Margin (2021-2026)
      • 13.9.4 Jiangxi Yaodu Renhe Pharmaceutical Co., Ltd. Main Business Overview
      • 13.9.5 Jiangxi Yaodu Renhe Pharmaceutical Co., Ltd. Latest Developments
  • 14 Research Findings and Conclusion

USD 7,320 or Partial Purchase
*Prices are subject to change by the publisher.
© 2026 ShareFair Inc.